SignatureFD’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-394
| Closed | -$7.66K | – | 3325 |
|
|
2023
Q2 | $7.66K | Sell |
394
-1,167
| -75% | -$22.7K | ﹤0.01% | 2345 |
|
|
2023
Q1 | $44.3K | Buy |
1,561
+1,036
| +197% | +$29.4K | ﹤0.01% | 1457 |
|
|
2022
Q4 | $15.3K | Buy |
525
+59
| +13% | +$1.73K | ﹤0.01% | 1936 |
|
|
2022
Q3 | $12K | Sell |
466
-225
| -33% | -$5.79K | ﹤0.01% | 2008 |
|
|
2022
Q2 | $31K | Buy |
691
+544
| +370% | +$24.4K | ﹤0.01% | 1553 |
|
|
2022
Q1 | $7K | Buy |
147
+59
| +67% | +$2.81K | ﹤0.01% | 2362 |
|
|
2021
Q4 | $4K | Sell |
88
-35
| -28% | -$1.59K | ﹤0.01% | 2524 |
|
|
2021
Q3 | $7K | Buy |
123
+12
| +11% | +$683 | ﹤0.01% | 2256 |
|
|
2021
Q2 | $5K | Buy |
111
+19
| +21% | +$856 | ﹤0.01% | 2306 |
|
|
2021
Q1 | $4K | Sell |
92
-3
| -3% | -$130 | ﹤0.01% | 2280 |
|
|
2020
Q4 | $4K | Hold |
95
| – | – | ﹤0.01% | 2073 |
|
|
2020
Q3 | $4K | Buy |
95
+74
| +352% | +$3.12K | ﹤0.01% | 2009 |
|
|
2020
Q2 | $1K | Buy |
+21
| New | +$1K | ﹤0.01% | 2403 |
|